Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Reticulocyte hemoglobin content is the best indicator of iron deficiency in women with diffuse non-scarring hair loss.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

A standardized guideline would improve Telogen Effluvium management.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

There's no link between low iron levels and the hair loss condition, alopecia areata.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Ayurveda treats hair problems like hair loss and dandruff by balancing body elements and using natural remedies like Indian Gooseberry and false Daisy.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Monilethrix causes short, fragile hair with no specific treatment available.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Human skin's melanocytes respond to light by changing shape, producing pigments and hormones, which may affect sleep patterns.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Iron is crucial for skin health, with specific proteins recycling it to support skin functions and prevent its release.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Low iron and vitamin D levels are linked to hair loss in women.

Testosterone boosts red blood cell production and changes iron metabolism without needing dihydrotestosterone.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Women with hair loss may benefit from higher iron levels.

Liver damage in PCOS is linked to iron overload and cell death due to the miR-761-hepcidin/GPX4 pathway.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Iron deficiency in menstruating women causes many health issues beyond anemia and needs early detection and treatment.

Transferrin receptor expression increases iron in mouse skin cells without causing damage.

ATE is linked to FAA, and treatment depends on cause; minoxidil helps, finasteride may worsen.